Anti-myostatin

Clinical trials for Anti-myostatin explained in plain language.

Never miss a new study

Get alerted when new Anti-myostatin trials appear

Sign up with your email to follow new studies for Anti-myostatin, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1 Completed 1

New Muscle-Boosting drug shows promise for SMA patients in major trial

Disease control Completed

This Phase 3 trial tested apitegromab, a drug that blocks a muscle-limiting protein, in 188 nonambulatory children and young adults with later-onset spinal muscular atrophy (SMA types 2 and 3). All participants were already taking standard SMA therapies (nusinersen or risdiplam).…

Matched conditions: ANTI-MYOSTATIN

Phase 3 • Sponsor: Scholar Rock, Inc. • Aim: Disease control

Last updated Jun 27, 2026 08:13 UTC

Anti-myostatin

Get alerted when new Anti-myostatin trials appear

New Muscle-Boosting drug shows promise for SMA patients in major trial